GURUFOCUS.COM » STOCK LIST » USA » NAS » CME Group Inc (NAS:CME) » Definitions » ROE %
Switch to:

CME Group ROE %

: 9.39% (As of Jun. 2022)
View and export this data going back to 2002. Start your Free Trial

ROE % is calculated as Net Income attributable to Common Stockholders (Net Income minus dividends to participating security holders) divided by its average Total Stockholders Equity over a certain period of time. CME Group's annualized net income attributable to common stockholders for the quarter that ended in Jun. 2022 was $2,616 Mil. CME Group's average Total Stockholders Equity over the quarter that ended in Jun. 2022 was $27,869 Mil. Therefore, CME Group's annualized ROE % for the quarter that ended in Jun. 2022 was 9.39%.

The historical rank and industry rank for CME Group's ROE % or its related term are showing as below:

CME' s ROE % Range Over the Past 10 Years
Min: 4.17   Med: 7.77   Max: 19.01
Current: 10.53

During the past 13 years, CME Group's highest ROE % was 19.01%. The lowest was 4.17%. And the median was 7.77%.

CME's ROE % is ranked better than
62.01% of 745 companies
in the Capital Markets industry
Industry Median: 7.04 vs CME: 10.53

CME Group ROE % Historical Data

The historical data trend for CME Group's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CME Group Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
ROE %
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.01 8.12 8.13 8.03 9.74

CME Group Quarterly Data
Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
ROE % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.66 13.71 8.86 10.19 9.39

Competitive Comparison

For the Financial Data & Stock Exchanges subindustry, CME Group's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

CME Group ROE % Distribution

For the Capital Markets industry and Financial Services sector, CME Group's ROE % distribution charts can be found below:

* The bar in red indicates where CME Group's ROE % falls into.



CME Group ROE % Calculation

CME Group's annualized ROE % for the fiscal year that ended in Dec. 2021 is calculated as

ROE %=Net Income attributable to Common Stockholders (A: Dec. 2021 )/( (Total Stockholders Equity (A: Dec. 2020 )+Total Stockholders Equity (A: Dec. 2021 ))/ count )
=2617.1/( (26319.9+27399.3)/ 2 )
=2617.1/26859.6
=9.74 %

CME Group's annualized ROE % for the quarter that ended in Jun. 2022 is calculated as

ROE %=Net Income attributable to Common Stockholders (Q: Jun. 2022 )/( (Total Stockholders Equity (Q: Mar. 2022 )+Total Stockholders Equity (Q: Jun. 2022 ))/ count )
=2616.4/( (27736.8+28001.7)/ 2 )
=2616.4/27869.25
=9.39 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income attributable to common stockholders of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income attributable to common stockholders data used here is four times the quarterly (Jun. 2022) net income attributable to common stockholders data. ROE % is displayed in the 30-year financial page.


CME Group  (NAS:CME) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %**(Q: Jun. 2022 )
=Net Income/Total Stockholders Equity
=2650/27869.25
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(2650 / 4948.8)*(4948.8 / 191294.5)*(191294.5 / 27869.25)
=Net Margin %*Asset Turnover*Equity Multiplier
=53.55 %*0.0259*6.864
=ROA %*Equity Multiplier
=1.39 %*6.864
=9.51 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %**(Q: Jun. 2022 )
=Net Income/Total Stockholders Equity
=2650/27869.25
=(Net Income /Pre-Tax Income) * (Pre-Tax Income/Operating Income) * (Operating Income/Revenue) * (Revenue/Total Assets) * (Total Assets/Total Stockholders Equity)
= (2650 / 3466.8) * (3466.8 / 2998.8) * (2998.8 / 4948.8) * (4948.8 / 191294.5) * (191294.5 / 27869.25)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.7644 * 1.1561 * 60.6 % * 0.0259 * 6.864
=9.51 %

Note: The net income attributable to common stockholders data used here is four times the quarterly (Jun. 2022) net income attributable to common stockholders data. The Revenue data used here is four times the quarterly (Jun. 2022) revenue data. The same rule applies to Pre-Tax Income and Operating Income.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.


Be Aware

Net income attributable to common stockholders is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


CME Group ROE % Related Terms

Thank you for viewing the detailed overview of CME Group's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


CME Group Business Description

CME Group logo
Address
20 South Wacker Drive, Chicago, IL, USA, 60606
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The CME was founded in 1898 and in 2002 completed its initial public offering. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival, CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P/Dow Jones Indices LLC, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX in 2018 it has also expanded into cash foreign exchange, fixed income trading, and collateral optimization.
Executives
Mccourt Timothy Francis officer: Sr MD Global Head Equity & FX 20 S WACKER DRIVE CHICAGO IL 60606
Fitzpatrick Lynne officer: Sr MD Deputy CFO 20 S WACKER DRIVE CHICAGO IL 60606
Sprague Suzanne officer: Sr MD Global Head of Clearing 20 SOUTH WACKER DRIVE 18S CHICAGO IL 60606
Dennis Michael G. director 20 S. WACKER DR. CHICAGO IL 60606
Maloney Patrick W director 20 S. WACKER DR. CHICAGO IL 60201
Mulchrone Patrick J director 20 S. WACKER DR. CHICAGO IL 60606
Seifu Rahael director 20 S. WACKER CHICAGO IL 60606
Harris Yra G director 20 S. WACKER DR CHICAGO IL 60606
Lockett Phyllis M director 20 S. WACKER DR. CHICAGO IL 60606
Tierney Robert J Jr director 20 S. WACKER DR. CHICAGO IL 60606
Kaye Daniel G director 1742 APPLEBY ROAD INVERNESS IL 60067
Spencer Michael A director 20 S. WACKER DR. CHICAGO IL 60606
Lucas Deborah J director C/O ANTHRACITE CAPITAL, INC. 40 EAST 52ND STREET NEW YORK NY 10022
Hertshten Gedon director 20 S. WACKER DR. CHICAGO IL 60606
Winkler Julie officer: Chief Commercial Officer 20 S. WACKER DR. CHICAGO IL 60606

CME Group Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)